[Levofloxacin in obstetrics and gynecology].

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1992 Japanese Publisher:Japan Antibiotics Research AssociationJournal:The Japanese journal of antibiotics, volume 45 (issn: 0368-2781,

Copyright policy )

Authors: CHIMURA, TETSURO; MORISAKI, NOBUYUKI; FUNAYAMA, TOHRU; ODA, TAKAHARU;

pmid: 1512945

[Levofloxacin in obstetrics and gynecology].

- Summary
- Subjects
- Metrics

Abstract

We investigated the clinical efficacy and the safety of levofloxacin (LVFX, DR-3355) in obstetrical and gynecological infections and the following results were obtained. 1. Clinical efficacies were evaluated as excellent in 2 and good in 9 cases, hence the efficacy rate was 100%. 2. Bacteriologically, the eradication rate was 16/17 (94.1%). 3. No Side effects nor abnormal changes in laboratory test results were observed. These results indicated that LVFX was highly useful in the treatment of obstetrical and gynecological infections.

Related Organizations

Yamagata University
Japan

Keywords

Adult, Ofloxacin, Levofloxacin, Middle Aged, Uterine Cervicitis, Drug Evaluation, Humans, Female, Endometritis, Pelvic Inflammatory Disease

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average